September 1, 2021
Paradigm4's Marilyn Matz and Zachary Pitluk discuss the challenges of integrating data from heterogeneous sources and how the company's plaform and apps combine the cutting edge of computer science and a sensibility geared toward the unique needs of pharma and biopharma to provide end-to-end solutions.
Marilyn Matz is CEO and co-founder, along with Turing laureate Michael Stonebreaker, of Paradigm4. The scientific analytics solutions company enables scientists and data scientists to transform their research with an integrative analytics platform that powers massively scalable analytics and machine-learning. Prior to Paradigm4, after completing a MS degree at the MIT AI lab, she was one of three co-founders of Cognex Corporation, now a publicly-traded, global industrial machine vision company. Marilyn was the recipient of the sixth annual Women Entrepreneurs in Science and Technology (WEST) Leadership Award; a co-recipient of the SEMI industry award for outstanding technical contributions to the semiconductor industry; and a 2020 NACD Directorship 100.